[1]林素梅,吕 聪,杨小叶,等.利奈唑胺治疗新生儿革兰阳性球菌败血症的疗效[J].医学信息,2020,33(05):142-143.[doi:10.3969/j.issn.1006-1959.2020.05.045]
　LIN Su-mei,Lyu Cong,YANG Xiao-ye,et al.Effect of Linezolid in the Treatment of Neonatal Gram-positive Cocci Sepsis[J].Medical Information,2020,33(05):142-143.[doi:10.3969/j.issn.1006-1959.2020.05.045]
点击复制

利奈唑胺治疗新生儿革兰阳性球菌败血症的疗效()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年05期
页码:
142-143
栏目:
药物与临床
出版日期:
2020-03-01

文章信息/Info

Title:
Effect of Linezolid in the Treatment of Neonatal Gram-positive Cocci Sepsis
文章编号:
1006-1959（2020）05-0142-02
作者:
林素梅; 吕 聪; 杨小叶; 等
（广西壮族自治区民族医院药剂科1，新生儿科2，广西 南宁 530001）
Author(s):
LIN Su-mei; Lyu Cong; YANG Xiao-ye; et al
(Department of Pharmacy1,Department of Neonatal2,National Hospital of Guangxi Zhuang Autonomous Region,Nanning 530001,Guangxi,China)
关键词:
利奈唑胺; 万古霉素; 新生儿败血症
Keywords:
Linezolid; Vancomycin; Neonatal septicemia
分类号:
R722.1
DOI:
10.3969/j.issn.1006-1959.2020.05.045
文献标志码:
A
摘要:
目的 探讨利奈唑胺治疗新生儿革兰阳性球菌败血症的疗效及安全性。方法 收集2017年1月~2019年1月我院收治的新生儿革兰阳性球菌败血症50例，按照随机数字表法分为观察组（26例）和对照组（24例）。对照组采用万古霉素治疗，观察组采用利奈唑胺治疗，比较两组病原菌分布、细菌清除率、临床疗效和不良反应。结果 两组病原菌分布、治疗7、14 d后细菌清除率比较，差异无统计学意义（P＞0.05）。治疗后，观察组临床总有效率为92.31%，高于对照组的91.67%，但差异无统计学意义（P＞0.05）；观察组不良反应发生率为11.54%，高于对照组的4.17%，但差异无统计学意义（P＞0.05）。结论 利奈唑胺对新生儿革兰阳性菌所致败血症具有良好疗效，与万古霉素相比可取得相同的效果，且不良反应轻微。
Abstract:
Objective To investigate the efficacy and safety of linezolid in the treatment of neonatal gram-positive cocci sepsis. Methods 50 cases of neonatal Gram-positive cocci sepsis treated in our hospital from January 2017 to January 2019 were collected and divided into observation group (26 cases) and control group (24 cases) according to the random number table method. The control group was treated with vancomycin, and the observation group was treated with linezolid. The distribution of pathogens, bacterial clearance, clinical efficacy, and adverse reactions were compared between the two groups.Results Comparison of pathogen distribution and bacterial clearance between the two groups, the difference was not statistically significant (P>0.05). After treatment, the total clinical effective rate in the observation group was 92.31%, which was higher than 91.67% in the control group, but the difference was not statistically significant (P>0.05); the incidence of adverse reactions in the observation group was 11.54%, which was higher than the control group at 4.17% , but the difference was not statistically significant (P>0.05).Conclusion Linezolid has a good curative effect on sepsis caused by gram-positive bacteria in neonates. Compared with vancomycin, it can achieve the same effect with minor adverse reactions.

参考文献/References:

[1]邵肖梅,叶鸿瑁,丘小汕.实用新生儿学(第4版)[M].北京:人民卫生出版社,2011:340-347．[2]张冰,张卫星,齐攀,等.万古霉素和利奈唑胺治疗新生儿革兰阳性菌败血症的临床疗效及安全评价[J].齐齐哈尔医学院学报,2017,38(21):2522-2523.[3]中华医学会儿科学分会新生儿学组,《中华医学会中华儿科杂志》编辑委员会.新生儿败血症诊疗方案[J].中华儿科杂志,2003,41(12):897-899.[4]付盼,王传清,俞蕙,等.中国儿童细菌耐药监测组2017年儿童细菌感染及耐药监测[J].中国循证儿科杂志,2018,(6):406-411.[5]唐莲,方洁,王三南,等.万古霉素和利奈唑胺治疗新生儿革兰阳性菌败血症的临床疗效及安全评价[J].中华儿科杂志,2016,54(9):686-691.[6]张丽.万古霉素与利奈唑胺治疗新生儿革兰阳性菌败血症临床疗效及对胆红素和血小板的影响比较[J].儿科药学杂志,2018,24(11):7-10.

相似文献/References:

[1]刘代华,罗宜辉.肾功能亢进及对药物代谢的影响[J].医学信息,2019,32(09):48.[doi:10.3969/j.issn.1006-1959.2019.09.016]
　LIU Dai-hua,LUO Yi-hui.Hyperkalemia and Effects on Drug Metabolism[J].Medical Information,2019,32(05):48.[doi:10.3969/j.issn.1006-1959.2019.09.016]
[2]张成汉.夫西地酸钠和万古霉素用于ICU病房耐甲氧西林 金黄色葡萄球菌患者的疗效比较[J].医学信息,2019,32(18):149.[doi:10.3969/j.issn.1006-1959.2019.18.051]
　ZHANG Cheng-han.Efficacy Comparison of Sodium Fusidate and Vancomycin to Treat Patients with Methicillin-resistant Staphylococcus Aureus in ICU Ward[J].Medical Information,2019,32(05):149.[doi:10.3969/j.issn.1006-1959.2019.18.051]
[3]刘 岩.利奈唑胺联合莫西沙星治疗结核性脑膜炎的效果[J].医学信息,2019,32(16):131.[doi:10.3969/j.issn.1006-1959.2019.16.043]
　LIU Yan.Effect of Linezolid Combined with Moxifloxacin on Tuberculous Meningitis[J].Medical Information,2019,32(05):131.[doi:10.3969/j.issn.1006-1959.2019.16.043]
[4]刘旭良,李伯庭,郑介柏,等.负压封闭引流技术联合外用万古霉素治疗骶尾部难愈性压疮的效果[J].医学信息,2022,35(17):37.[doi:10.3969/j.issn.1006-1959.2022.17.008]
　LIU Xu-liang,LI Bo-ting,ZHENG Jie-bo,et al.Effect of Vacuum Sealing Drainage Combined with Topical Vancomycin in the Treatment of Sacrococcygeal Refractory Pressure Sores[J].Medical Information,2022,35(05):37.[doi:10.3969/j.issn.1006-1959.2022.17.008]
[5]仇晓威.群体药动学方法调整患者万古霉素使用效果的分析[J].医学信息,2023,36(22):97.[doi:10.3969/j.issn.1006-1959.2023.22.021]
　QIU Xiao-wei.Analysis of the Effect of Population Pharmacokinetic Methodon Adjusting the use of Vancomycin in Patients[J].Medical Information,2023,36(05):97.[doi:10.3969/j.issn.1006-1959.2023.22.021]

更新日期/Last Update: 2020-03-01